Market Overview

Breast Cancer Partnership Raises over Half a Million Dollars for Research into Inflammatory Breast Cancer and More


Susan G. Komen®, the Milburn Foundation and the Inflammatory Breast
Cancer Research Foundation today announced that they have raised nearly
$550,000 to fund research into inflammatory breast cancer (IBC)
as well as other critical breast cancer research and community health
programs. IBC is a less common but very aggressive form of breast cancer.

the month of March
, Milburn and the Inflammatory Breast Cancer
Research Foundation teamed up to match all donations made to Komen up to
a predetermined goal – a campaign which ultimately raised more than half
a million dollars, and exceeded the goal ten-fold. In total, over
$548,000 was raised through the campaign, which will support, in part,
research aimed at finding new ways of detecting and treating IBC.

This marks the second time the three organizations have partnered to
advance IBC research. Last fall, the partners announced two funding
opportunities for investigators with novel ideas about diagnosis and
treatment of IBC. Recipients of these awards include:

  • John Martens, Ph.D., from Erasmus Universitair Medisch Centrum
    , who received funding to combine patient information
    from an established Dutch IBC registry with the latest genomic
    technology to improve the diagnosis, monitoring, and treatment of IBC.
  • Mihaela Skobe, Ph.D., from the Icahn School of Medicine at Mount
    also received funding to understand how the interactions
    between Triple
    IBC and the lymphatic system influence the aggressiveness
    of the disease, ultimately providing insight on potential new
    treatment strategies.

"Our partnership has already allowed us to fund important research, and
will go a long way toward helping to reduce deaths from breast cancer,"
said Ellen Willmott, interim President and CEO for Susan G. Komen.
"Komen has set a Bold Goal to reduce the current number of breast cancer
deaths by 50 percent in the U.S. by 2026, but we know we will not be
able to achieve this alone – only as a community, which is why our
partnership with the Milburn Foundation and the Inflammatory Breast
Cancer Research Foundation is so valuable."

"The success of this partnership proves that strategic collective action
across multiple charities can yield powerful results for specialized
research," said Bryon Davis, President of the Milburn Foundation. "This
partnership was actively designed and facilitated for results, requiring
all parties to look at challenges in new ways and leveraging each
organization's strengths."

"Research progress, in a disease like IBC, requires vision, creative
thinking and action. Through the collaborative IBC research grants and
the recent matching gift campaign we're developing a new model for
meeting the needs of those facing an IBC diagnosis," said Ginny Mason,
RN, BSN, Executive Director of the IBC Research Foundation.

A portion of the funds from the March campaign will be used to provide
additional research support to the most promising of the two recipients
named above, following a review of their progress to date and other
prerequisites. To date, Komen has invested $9.1 million into research
focused on IBC – part of the organization's $920
million research
investment since its founding in 1982.

About Susan G. Komen®

Susan G. Komen is the world's largest breast cancer organization,
funding more breast cancer research than any other nonprofit outside of
the federal government while providing real-time help to those facing
the disease. Komen has set a Bold Goal to reduce the current number of
breast cancer deaths by 50 percent in the U.S. by 2026. Since its
founding in 1982, Komen has funded more than $920 million in research
and provided more than $2 billion in funding to screening, education,
treatment and psychosocial support programs serving millions of people
in more than 30 countries worldwide. Komen was founded by Nancy G.
Brinker, who promised her sister, Susan G. Komen, that she would end the
disease that claimed Suzy's life. That promise has become Komen's
promise to all people facing breast cancer. Visit
or call 1-877 GO KOMEN. Connect with us on social at

About The Milburn Foundation

The Milburn Foundation is a private charity that actively structures
creative partnerships with corporations and other charities to drive
philanthropic innovation for targeted causes like breast cancer. Large
or small companies interested in inventive Corporate Social
Responsibility (CSR) solutions may have an opportunity to double or
triple their impact through Milburn Foundation programs. The Milburn
Foundation is the proud recipient of the 2016 Susan G. Komen Reach Award
fundraising innovation
) and the Milburn Foundation is delighted to
join the ranks of Conde
 and other notable organizations who previously won this award.
Find out more by visiting

About IBC Research Foundation

Since 1999 the Inflammatory Breast Cancer Research Foundation (IBCRF)
has been leading the way in improving the lives of those touched by
inflammatory breast cancer (IBC) through the power of action and
advocacy. This is accomplished by tenaciously fostering innovative
research, creatively educating stakeholders, and tirelessly advocating
for both current IBC patients and survivors.

As a web-based non-profit, IBCRF relies on its dedicated volunteers
across the country. Guided by the Medical Advisory Board, a group
of extraordinary oncology professionals, IBCRF has funded
patient-focused IBC research resulting in new discoveries as well
as clinical trials. Learn more at or
call 1-877-stop ibc. On social media? Join us on
 and Twitter (@IBCResearch)

View Comments and Join the Discussion!